WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement after President Trump signed H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act, into law.

“Today, America celebrates the passage of the SUPPORT for Patients and Communities Reauthorization Act—legislation that takes significant steps toward reducing the toll illicit fentanyl and fentanyl-related substances take on our communities. As the Chairman of the House Committee on Energy and Commerce, I’m proud of the bipartisan work that has been done through this important legislation to continue empowering first responders, supplying recovery resources, and increasing access to treatment options for individuals with substance use disorders,” said Chairman Guthrie. “I want to thank President Trump for his continued commitment to combatting the opioid crisis, and the reauthorization of this legislation ensures continued investment in prevention, recovery, and hope for families nationwide.”

Background:

• H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025, was reported to the full House from the Committee on Energy and Commerce by a roll call vote of 36 yeas – 13 nays and passed the full House by a vote of 366 yeas – 57 nays. 
• The Senate passed the legislation by unanimous consent on September 18.
• The SUPPORT Act: 
• Ensures first responders can access and administer naloxone; 
• Allows for enhanced SUD treatment options for pregnant and postpartum women; 
• Strengthens state PDMP systems; 
• Encourages individuals in recovery to participate in the workforce; and 
• Continues the supply of resources for Comprehensive Opioid Recovery Centers, which provide a full spectrum of treatment and recovery support services.

###